share_log
Moomoo 24/7 ·  Mar 12 06:11
Ideaya Biosciences Has Entered Into A Clinical Trial Collaboration And Supply Agreement With Merck To Evaluate Its IDEE161 In Combination With Keytruda (Pembrolizumab) For Endometrial Cancer, In A Phase 1 Trial
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment